FDA Cannot Ensure Safety Of Imported Prescription Drugs
"Because of the wide-ranging scope of counterfeiting, it's nearly impossible for [FDA]to guarantee the safety of imported drugs, even if they enter the U.S.from supposedly reputable nations," Peter Pitts, president of the Center for Medicine in the Public Interest and founding member of FDA's Counterfeit Drug Task Force, writes in a Chicago Tribuneopinion piece.
Pitts continues that "simply mandating safety bylegislative fiat will not make imported drugs safer" and that"without fundamental regulatory reforms in the countries wherecounterfeits are produced, the FDA's efforts will be futile."
Accordingto Pitts, "Allowing the importation of prescription drugs with theostensible purpose of saving consumers a few bucks is a dangerousresponse to high drug prices." He added, "Congress has a responsibilityto protect Americans from overseas threats, not expose them to thosehazards" (Pitts, Chicago Tribune, 7/8).
Reprinted with permission fromkaisernetwork.org.You can view the entire KaiserDaily Health Policy Report, search the archives, andsign up for email delivery at kaisernetwork.org/email. The Kaiser Daily Health Policy Report is published forkaisernetwork.org,a free service of The Henry J. Kaiser Family Foundation.